Karo Healthcare has expanded its OTC offering in Italy with the acquisition of hemorrhoid treatment Proctosedyl from Bayer for an undisclosed sum.
Under the terms of the asset deal, Karo gains exclusive license to the Proctosedyl trademark in Italy, as well as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?